One million signatures needed to call upon World Health Organisation
The 1 Mission 1 Million - Getting to the Heart of Stroke initiative is...
Biomarker predicts response to cancer treatment
VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might...
FDA approves generic versions of blood thinner Plavix
The U.S. Food and Drug Administration approved generic versions of the blood thinning drug...
Amgen’s BiTEĀ® antibody blinatumomab achieved high rate of complete response
Amgen announced updated results from a Phase 2 study that showed treatment with blinatumomab...
In drug-approval race, US FDA ahead of Canada, Europe
The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier...
Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on DiabetesĀ® to China and...
The Bristol-Myers Squibb Foundation today announced the expansion of its Together on DiabetesĀ® initiative...
Serious safety concerns around unlicensed ocular bevacizumab use versus Lucentis
Ā Recently announced results from two-year CATT (Comparison of Age-related macular degeneration Treatment Trials) adds...
AstraZeneca to acquire Ardea Biosciences for $1 billion
AstraZeneca and Ardea Biosciences, Inc. have entered into a definitive merger agreement, pursuant to which...
Key protein responsible for controlling nerve cell protection
A key protein, which may be activated to protect nerve cells from damage during...
Rosetta wins European patent covering core element of microRNA technology
Rosetta Genomics has won a European patent covering the use of miR-34a in the...